EMMANUEL HRISO: Open Payments
NPI 1942217328 · WOODBRIDGE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 83 payments from 13 companies in 2025. Trend: 2023 $1,184 · 2024 $1,593 · 2025 $1,479
Food & beverage: $1,367Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $528 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $195 |
| Teva Pharmaceuticals USA, Inc. | 4 | $161 |
| Lundbeck LLC | 10 | $156 |
| Tris Pharma Inc | 5 | $83 |
| Vanda Pharmaceuticals Inc. | 5 | $77 |
| Axsome Therapeutics, Inc. | 5 | $75 |
| Alkermes, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
Products named: VRAYLAR, CAPLYTA, REXULTI, Dyanavel XR, FANAPT, ARISTADA, AUSTEDO XR, Sunosi.
Industry payments across NJ — which companies pay providers there.
